Pelecanam

培来加南

Report date: 2026/05/11 20:01:57
NME

Base Information

Drug NamePelecanam
Drug Alias NamePL-5
ClassificationSmall molecules > Synthetic peptideSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsAcute bacterial skin and skin structure infectionsUlcerFolliculitis +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesPle Pharmacy (Jiangsu) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesPle Pharmacy (Jiangsu) Co LtdChangchun Pulai Pharmaceutical Biotechnology Co LtdJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAcute bacterial skin and skin structure infectionsDiabetic FootWound Infection
Inactive IndicationsUlcerFolliculitisSkin Diseases, Infectious +[5] 

Other Information

ATC CodeN/A
Related LinksN/A